Women's uptake of non‐invasive DNA testing following a high‐risk screening test for trisomy 21 within a publicly funded healthcare system: findings from a retrospective review

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0223|35|4|342-347

ISSN： 0197-3851

Source： PRENATAL DIAGNOSIS, Vol.35, Iss.4, 2015-04, pp. : 342-347

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non‐invasive prenatal testing for trisomy 21 based on analysis of cell‐free fetal DNA circulating in the maternal plasma

By  

PRENATAL DIAGNOSIS, Vol. 35, Iss. 5, 2015-05 ,pp. : 471-476

John Wiley & Sons Inc

Access to resources Recommend Favorite

Women's preference for non‐invasive prenatal DNA testing versus chromosomal microarray after screening for Down syndrome: a prospective study

By  

BJOG : AN INTERNATIONAL JOURNAL OF OBSTETRICS & GYNAECOLOGY, Vol. 125, Iss. 4, 2018-03 ,pp. : 451-459

John Wiley & Sons Inc

Access to resources Recommend Favorite

History of high‐risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: Experience from the largest women's hospital in China

By  

CANCER CYTOPATHOLOGY, Vol. 123, Iss. 7, 2015-07 ,pp. : 421-427

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 45, Iss. 5, 2015-05 ,pp. : 530-538

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐trimester detection of abnormally invasive placenta in high‐risk women: systematic review and meta‐analysis

By  

ULTRASOUND IN OBSTETRICS & GYNECOLOGY, Vol. 51, Iss. 2, 2018-02 ,pp. : 176-183

John Wiley & Sons Inc

Access to resources Recommend Favorite